Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma × ixabepilone × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Neoplasms 9 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Ovarian Epithelial 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Ovarian Neoplasms 4 Breast Neoplasms, Male 4 Carcinoma, Renal Cell 3 Wilms Tumor 2 Testicular Neoplasms 2 Teratoma 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Salivary Gland Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 24 Paclitaxel 21 Gemcitabine 17 Cisplatin 16 pembrolizumab 12 Everolimus 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 7 Pemetrexed 7 Fluorouracil 7 130-nm albumin-bound paclitaxel 7 Radiotherapy 6 Nivolumab 6 Cetuximab 6 Panitumumab 5 Cyclophosphamide 5 Bevacizumab 5 Axitinib 5 trebananib 4 lenvatinib 4 Sunitinib 4 Sorafenib 4 Irinotecan 4 Gefitinib 4 volociximab 3 reolysin 3 padeliporfin 3 epothilone B 3 durvalumab 3 Octreotide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02915744 2023-04-14

ATTAIN

Nektar Therapeutics

Phase 3 Completed

178 enrolled 37 charts

Breast Neoplasms, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡